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Abstract
Folding of proteins entering the secretory pathway in mammalian
cells frequently requires the insertion of disulfide bonds. Disulfide
insertion can result in covalent linkages found in the native struc-
ture as well as those that are not, so-called non-native disulfides.
The pathways for disulfide formation are well characterized, but
our understanding of how non-native disulfides are reduced so
that the correct or native disulfides can form is poor. Here, we use
a novel assay to demonstrate that the reduction in non-native
disulfides requires NADPH as the ultimate electron donor, and a
robust cytosolic thioredoxin system, driven by thioredoxin reduc-
tase 1 (TrxR1 or TXNRD1). Inhibition of this reductive pathway
prevents the correct folding and secretion of proteins that are
known to form non-native disulfides during their folding. Hence,
we have shown for the first time that mammalian cells have a
pathway for transferring reducing equivalents from the cytosol to
the ER, which is required to ensure correct disulfide formation in
proteins entering the secretory pathway.
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Introduction
The formation of disulfides within the mammalian endoplasmic
reticulum (ER) is a highly orchestrated process that occurs during
the folding and assembly of proteins entering the secretory pathway
(Braakman & Bulleid, 2011). The introduction of disulfides is cata-
lyzed by a family of disulfide exchange proteins typified by protein
disulfide isomerase (PDI; Ellgaard & Ruddock, 2005). The disulfide
within their active sites is exchanged with free thiols within a fold-
ing polypeptide chain as it enters the lumen of the ER. The
mechanism for the reoxidation of the PDI active site can involve
multiple pathways that couple the introduction of a disulfide with
the reduction in an electron acceptor such as oxygen or hydrogen
peroxide (Bulleid & Ellgaard, 2011). The disulfide formed within the
folding polypeptide may be the same as that found in the native
state, but can also form between two thiols not linked in the final
structure (Jansens et al, 2002). Such non-native disulfides need to
be resolved for the polypeptide to attain its native state. In addition,
disulfides in proteins that are targeted for degradation may be
reduced prior to their dislocation from the ER to the cytosol (Ushioda
et al, 2008; He et al, 2015). Hence, in parallel to an oxidative path-
way, a reductive pathway must exist in the ER to ensure correct
protein folding and allow dislocation of proteins for degradation.
The initial stage in the reduction in non-native disulfides is cata-
lyzed by members of the PDI family such as ERdj5 (Ushioda et al,
2008; Oka et al, 2013). This enzyme is characterized by four thiore-
doxin (Trx) fold domains which have active site dithiol/disulfides
motifs with relatively low reduction potential making it an efficient
reductase and the presence of a J domain which can bind to the ER
chaperone BiP (Cunnea et al, 2003; Hagiwara et al, 2011).
Substrates are likely to be targeted to ERdj5 due to their binding to
BiP via hydrophobic regions which may be exposed during folding
(Fourie et al, 1994). Many of the substrates for ERdj5 contain
several independent folding domains as well as multiple disulfides
increasing their potential to interact with BiP and form non-native
disulfides. Most notably, formation of the active site disulfides and a
functional J domain within ERdj5 are required for the correct folding
of substrate proteins (Oka et al, 2013).
During catalysis, the ERdj5 active site dithiol motifs will be
oxidized to disulfides and, therefore, require subsequent reduction
to allow further enzymatic activity. Within the cytosol, the main
disulfide reducing protein thioredoxin 1 (Trx1) is maintained in a
reduced state by the action of cytosolic TrxR1 with potential contri-
bution from both the glutathione reductase (GR) and glutaredoxin
(Grx) pathways (Lillig & Holmgren, 2007). However, there are no
known equivalent pathways present within the ER for the reduction
in disulfides in the Trx domains within the members of the PDI
family. A potential GR variant does exist in the ER, called ERFAD
(ER flavoprotein associated with degradation); however, it does not
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contain the active site cysteines essential for function as GR or TrxR
(Riemer et al, 2009). In prokaryotes, disulfide formation and reduc-
tion within the periplasmic space is catalyzed by the disulfide
exchange proteins DsbA and DsbC, which are structurally homolo-
gous to Trx1 (Kadokura et al, 2003). Disulfide formation is coupled
to the electron transport chain via a membrane protein called DsbB,
allowing de novo disulfide formation in the disulfide exchange
protein DsbA which catalyzes disulfide formation in substrate
proteins. The reductive pathway is coupled to bacterial TrxR within
the cytosol, by DsbD transferring electrons across the membrane to
reduce the disulfide exchange protein DsbC that finally catalyzes
disulfide reduction.
Previous attempts to identify the ER reductive pathway have
focused on the role of glutathione (GSH) in the process (Chakravarthi
et al, 2006). In particular, GSH has been shown to play an important
role in buffering the capacity of the ER from fluctuations in reductive
or oxidative stress ensuring a rapid re-equilibration of the redox status
of several members of the PDI family (Jessop & Bulleid, 2004; Molteni
et al, 2004; Appenzeller-Herzog et al, 2010). However, its require-
ment for the formation of the correct disulfides in proteins is less
clear. Depletion of ER GSH either by inhibition of GSH synthase or by
targeting GSH-degrading enzymes to this organelle did not prevent
correct disulfide formation in proteins containing complex disulfides
such as tissue-type plasminogen activator or the LDL-receptor
(Chakravarthi & Bulleid, 2004; Tsunoda et al, 2014). Even if GSH is
involved in the reductive pathway by reducing ERdj5, the resulting
glutathione disulfide (GSSG) formed would still need to be reduced
either enzymatically in the ER or following transport back into the
cytosol, by reaction with free thiols in proteins entering the ER or by
oxidation of other PDI family members (Bulleid & Ellgaard, 2011).
To provide insight into the reductive pathway involved in ensur-
ing that correct disulfides are formed within proteins, we took
advantage of a cell-free translation system that allowed us to selec-
tively manipulate the cytosolic reductive pathway. Importantly, we
have developed a system that allows us to assay the transition from
non-native to native disulfides during protein synthesis. Using this
approach, we were able to determine the consequence of manipula-
tion of the individual cytosolic reductive pathways on formation of
the correct disulfides in proteins entering the mammalian ER.
Results
The role of the Trx pathway in preventing disulfide formation in
the cytosol
Previous characterization of rabbit reticulocyte lysate systems for
cell-free translation has highlighted the requirement for reducing
equivalents to ensure efficient and sustained protein synthesis
(Jackson et al, 1983a,b). As a consequence of these studies, most
commercial lysates contain added reducing agents such as dithio-
threitol (DTT), which maintains protein synthesis but also prevents
disulfide formation. To be able to evaluate the endogenous reduc-
tive pathway during cell-free translation, we made use of a commer-
cial lysate that does not contain added DTT but still shows high
levels of protein synthesis (Wilson et al, 1995). When a variety of
protein transcripts were translated and the products separated by
SDS–PAGE under non-reducing conditions, it was noted that all
formed intra- and to some extent inter-chain disulfides as judged by
mobility shifts compared to the same samples run under reducing
conditions (Fig 1A–D, compare lanes 1 and 2). These transcripts
code for proteins normally located in the cytosol (c-VIMP, a soluble
Sec-to-Cys variant of SelS/VIMP lacking the transmembrane
domain, Fig 1A; Christensen et al, 2012) or the ER (influenza virus
hemagglutinin (HA), prolactin and b1-integrin, Fig 1B–D). This
result was unexpected as protein disulfides do not normally form
within the cytosol of mammalian cells and indicated that the reduc-
ing capacity of the reticulocyte cytosol extract had become compro-
mised during its preparation.
There are two major pathways that might prevent disulfide
formation in proteins synthesized in the cytosol, namely the Trx1/
TrxR1 or the GSH/GR/Grx pathway (Fig 2; Lu & Holmgren, 2014).
Both of these pathways use NADPH as the ultimate electron donor
so aberrant disulfide formation in the reticulocyte lysate could be
due to a lack of NADPH. The main mechanism for NADPH recycling
in the cytosol is through the action of glucose-6-phosphate dehydro-
genase (G6PDH), so to determine whether replenishing NADPH
could prevent disulfide formation, we included increasing concen-
tration of G6P during translation and evaluated the redox status of
the synthesized proteins (Fig 1). In all cases, disulfide formation
was prevented when the added G6P concentration exceeded
0.2 mM. This result demonstrates that NADPH is the most likely
electron donor and that we can re-establish the reducing environ-
ment in the cytosolic extract by the addition of G6P.
To determine which of the reductive pathways was involved in
preventing disulfide formation, we made use of inhibitors of G6PDH
(dehydroepiandrosterone—DHEA), TrxR1 (auranofin), or GR (car-
mustine). For these experiments, we used b1-integrin as it contains
several thiols capable of forming disulfides (Fig 3). Similar results
were observed when HA was translated in the presence of these inhi-
bitors (Fig EV1). Inhibiting G6PDH prevented the restorative effect of
G6P demonstrating that G6P prevents disulfide formation by the
regeneration of NADPH during its conversion to 6-phoshogluconolac-
tone (Fig 3A). As DHEA is a competitive inhibitor, its effects are
noticeable but not complete. A more dramatic effect was seen when
TrxR1 was irreversibly inhibited with auranofin (Fig 3B) at a concen-
tration that prevents the activity of the purified enzyme (Fig EV2).
Even at low lM concentrations, well below the concentrations
required to inhibit GR (Gromer et al, 1998; Fig EV2), the restorative
effect of G6P was reversed allowing disulfides to be formed (lanes
3–6). Remarkably, the GR inhibitor carmustine had no effect on the
disulfide reduction mediated by G6P at concentrations known to
inhibit the enzyme (Figs 3C and EV2; Liu & Sturla, 2009). Some slight
inhibition occurred at 3.66 mM with HA (Fig EV1) though it should
be noted that carmustine also inhibits TrxR1 at higher concentrations
(Fig EV2; Witte et al, 2005). Together these results suggest that the
main pathway that prevents disulfides forming in proteins synthe-
sized within a reticulocyte lysate is mediated by TrxR1 and not GR.
To evaluate further the role of the individual cytosolic reductive
pathways in preventing disulfide formation, we determined the
changes that occurred to either the Trx1 redox status or the GSSG/
GSH ratio after addition of G6P to the lysate. To determine the Trx1
redox state, we took advantage of the fact that modification of free
thiols with the alkylating agent 4-acetamido-40-maleimidylstilbene-2,
20-disulfonic acid (AMS) results in a decrease in electrophoretic
mobility of modified relative to unmodified proteins. We added
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purified streptavidin binding peptide-tagged Trx1 to the lysate as the
migration of the endogenous protein by SDS–PAGE was distorted by
the high concentration of globin in the lysate. We treated lysates,
either before or after incubation with G6P, with NEM to block free
thiols, and subsequently reduced and then alkylated with AMS so
that slower migrating bands indicate oxidized protein. In the
untreated sample, two bands were revealed for Trx indicating that
in the absence of G6P, Trx1 was partially oxidized (Fig 4A, lane 1).
After the lysate was treated with G6P, only a single Trx1 species
was present which migrated with the reduced form, indicating that
a consequence of the addition of G6P was the reduction in Trx1
(lane 2). We determined the redox state of Trx1 after G6P addition
but in the presence of auranofin (lane 3). Trx1 remained as a
mixture of oxidized and reduced forms demonstrating that the
reduction in Trx1 mediated by G6P addition required TrxR1.
To determine whether the consequence of G6P addition was to
alter the GSSG/GSH ratio, thereby preventing disulfide formation,
we monitored the change in GSSG/GSH ratio following G6P addition
(Fig EV2). Even in the absence of G6P, the ratio of GSSG/GSH was
low indicating that the lysate contained predominantly GSH. The
ratio did not change markedly following G6P addition indicating
that the ability of the lysate to support disulfide formation was not a
consequence of changes in the GSH redox balance.
Finally, to further determine the role of GSH in modulating disul-
fide formation, we depleted GSH from the lysate. To remove GSH,
we added a GSH-degrading enzyme called ChaC1 to the reticulocyte
lysate (Kumar et al, 2012). The total GSH levels were depleted to
< 10% following treatment (Fig 4B). It is likely that the residual
amount of GSH remaining is the oxidized form as ChaC1 does not
degrade GSSG (Tsunoda et al, 2014). The reticulocyte lysate was
still active in protein synthesis with extensive disulfide formation
occurring in the absence of added G6P using b1-integrin as substrate
(Fig 4C, lane 4). However, the addition of G6P prevented most of
this disulfide formation (lane 5). Hence, the removal of GSH does
not prevent the G6P-mediated reduction in disulfides.
Taken together, these results show a demonstrable effect of G6P
addition on the redox status of Trx1 and suggest that the pathway
for reduction in disulfides in the cytosol is maintained by the recy-
cling of NADP to NADPH, which drives the reduction in Trx1 by
TrxR1. The lack of change to the GSSG/GSH ratio and the
A B
C D
Figure 1. The formation of disulfides during cell-free translation of several proteins can be prevented by the addition of G6P.
A–D Cell-free translation with 35S-labeling of newly synthesized protein was carried out in the presence of increasing concentrations of G6P as indicated. The transcripts
used were (A) c-VIMP, (B) influenza virus HA, (C) preprolactin, and (D) b1-integrin. The samples were separated by SDS–PAGE under reducing (lane 1) or non-
reducing (lanes 2–7) conditions. The mobility of the reduced (red) or oxidized (ox) protein is as indicated.
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continuation of the reductive pathway following GSH depletion
would suggest that GR/GSH/Grx pathway is not responsible for
preventing disulfide formation in the cytosol, at least under the
conditions studied here. It should be noted, however, that it has
been shown previously that there is potential cross talk between the
Grx and Trx1 pathways (Reichheld et al, 2007).
The cytosolic reductive pathway drives the resolution of non-
native disulfides formed within the ER
We describe above the development of a cell-free translation system
that prevents disulfides forming in newly synthesized proteins with-
out the addition of exogenous reducing agents. To determine the
ability of the same system to support disulfide formation in proteins
translocated into the ER, we supplemented the lysate with semi-
permeabilized (SP) cells (Wilson et al, 1995). As previously
described (Jessop et al, 2007), when b1-integrin was translated in
the presence of SP cells an additional, slower migrating product
was observed that corresponds to the glycosylated protein (Fig 5A,
lane 1). When the same translation products were separated under
non-reducing conditions, a different migration pattern was observed
depending on the presence or absence of added G6P (Fig 5A, lanes
5 and 6). In the absence of G6P, a broad smear migrating faster
than the reduced glycosylated protein as well as higher molecular
weight aggregates was observed (lane 5). The smear would indicate
that disulfides had formed, but a heterogeneous mixture of species
was present containing correct and incorrect disulfides. As b1-
integrin contains 21 disulfides, it has a high potential to form the
incorrect disulfides. However, in the presence of G6P, a more
distinct, faster migrating product was observed with little evidence
of high molecular weight aggregates (lane 6). Importantly, disul-
fides were formed under conditions where no disulfides were
formed in the absence of SP cells (Fig 1D, lane 7). Indeed, the
untranslocated protein seen when translations were carried out in
SP cells was also fully reduced in the presence of G6P (Fig 5A, lane
6). Note that the mobility of the untranslocated protein separated
under reducing conditions is different after translation in the
absence or presence of G6P (Fig 5A, lanes 1 and 2). This is most
likely due to modification of free thiols by NEM slowing the
A
B
(i)
(ii)
Figure 2. Pathways for disulfide reduction in the cytosol.
A The TrxR1 pathway is driven by NADPH reducing Trx. The reduced Trx can
then efficiently reduce disulfides in substrate proteins (P).
B The GR pathway is also driven by NADPH resulting in the reduction in
glutathione disulfide. The GSH generated can either (i) directly reduce
disulfides in substrate proteins or (ii) reduce glutaredoxin (Grx) which then
reduces substrate proteins.
A B C
Figure 3. Inhibition of G6PDH or TrxR1 but not GR allows disulfide formation in the presence of G6P.
A–C Cell-free translation of b1-integrin was carried out in the presence of G6P and increasing concentrations of (A) DHEA, (B) auranofin (aur), or (C) carmustine (carm)
as indicated. The translation mixture was incubated for 10 min prior to the reaction being initiated by the addition of mRNA and incubation at 30°C. Translation
products were separated by SDS–PAGE after prior reduction with DTT (B and C, lane 1) or without reduction (A, lanes 1–3 or B and C, lanes 2–6).
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mobility of the protein synthesized in the presence of G6P. The
untranslocated protein seen when SP cells are included in the trans-
lation in the presence of G6P migrates at the same position as the
NEM-modified protein, further demonstrating the lack of disulfide
formation (Fig 5A, lane 6). Taken together, these results indicate
that the translocated, glycosylated b1-integrin synthesized in the
presence of SP cells formed a different set of disulfides in the pres-
ence of G6P than in its absence.
To determine whether native disulfides were formed in either the
presence or absence of G6P, we used a conformation-specific anti-
body (9EG7) which we have shown previously to immunoisolate
only b1-integrin that is correctly folded (Tiwari et al, 2011). Only
A B C
Figure 4. Trx1 is reduced following G6P addition, and GSH depletion does not prevent the G6P-mediated reduction in disulfides.
A The oxidation status of added Trx1 was assayed through immunoblotting following a 60-min incubation in a cell-free translation system in the absence or presence
of G6P with and without auranofin (aur) as indicated. Following incubation, Trx1 was isolated, reduced, and any free thiols released were modified with AMS which
retards electrophoretic mobility. Hence, the slower migrating band of the doublet is Trx1 that was oxidized in the original sample. The position of the reduced (red) or
oxidized (ox) protein is as indicated.
B Reticulocyte lysate was treated with or without 5 lM purified ChaC1 for 60 min prior to measuring the GSH concentration. The results are the average from three
separate determinations  SD.
C Cell-free translation of b1 integrin was carried out in the presence or absence of G6P as indicated and in normal (lanes 1–3) or GSH-depleted (lanes 4 and 5)
reticulocyte lysate. Samples were separated with (lane 1) or without (lanes 2–5) prior reduction with DTT.
A CB
Figure 5. Cytosolic TrxR1 activity is required to allow correct disulfide formation in proteins translocated into the ER.
A Translation of b1-integrin was carried out in the presence of SP cells and the absence or presence of G6P as indicated. Samples were separated with or without prior
reduction with DTT as indicated. Auranofin (aur; 20 lM) was either included in the reticulocyte lysate (L) during translation (lane 7) or the SP cells (C) were pre-
treated with auranofin (lane 8).
B Translations of b1-integrin carried out in the presence of SP cells (lanes 1 and 2) were subjected to immunoisolation with the conformation-specific antibody 9EG7
(lanes 3 and 4). Translations were carried out in the absence and presence of G6P as indicated and samples separated under non-reducing conditions.
C As in (A), but carmustine (carm; 1 mM) was used instead of auranofin.
ª 2017 The Authors The EMBO Journal
Greg J Poet et al Cytosolic TrxR1 system reduces ER disulfides The EMBO Journal
5
Published online: January 16, 2017 
the translation product synthesized in the presence of G6P was
immunoisolated by this antibody (Fig 5B) confirming that G6P
added to the cytosol was required to ensure the correct disulfides
were formed in b1-integrin. These results indicate that non-native
disulfides are formed in the translocated, glycosylated product in
the absence of G6P and that the NADPH recycled after G6P metabo-
lism is required to resolve these non-native disulfides to allow the
protein to fold correctly.
The reconstitution of the ER reductive pathway following G6P
addition could be due to the production of NADPH in the cytosol, as
shown above, or due to NADPH production within the ER following
G6P import and conversion to 6-phosphogluconate by the ER-
resident enzyme hexose 6-phosphate dehydrogenase (White et al,
2007). The NADPH produced could then be used by any putative
GR or TrxR within the ER lumen (Bulleid & van Lith, 2014). To eval-
uate these two possibilities, first we carried out translation in the
presence of SP cells and G6P and inhibited the cytosolic TrxR1 or
GR with auranofin or carmustine respectively. When added to the
reticulocyte lysate, auranofin blocked the effect of G6P addition
(Fig 5A, lanes 6 and 7) whereas carmustine had no effect (Fig 5C,
lanes 6 and 7). We then carried out a translation using SP cells that
had been pre-treated with auranofin or carmustine. As both these
inhibitors are irreversible, any putative ER-localized thioredoxin or
glutathione reductase would be inactivated. When these SP cells
were added to untreated lysate either in the presence or absence of
G6P, no effect of either inhibitor was seen on the ability of G6P to
prevent non-native disulfide formation (Fig 5A and C, lanes 6 and
8). These results demonstrate that the cytosolic TrxR1 but not the
GR pathway is required to resolve any non-native disulfides formed
during the synthesis and folding of b1-integrin following its translo-
cation into the ER lumen.
The thioredoxin reductase pathway is required for efficient
trafficking of proteins secreted from mammalian cells
The results presented above provide compelling evidence that the
cytosolic thioredoxin system is required to resolve non-native
disulfides within a functionally and morphologically intact ER. To
determine whether a similar requirement is evident in intact
mammalian cells grown in culture, we made use of well-character-
ized folding and secretion of the LDLr which has been shown to
form non-native disulfides as part of its normal folding pathway
(Jansens et al, 2002). To determine the role of cytosolic thiore-
doxin reductase (TrxR1) in the folding and secretion of LDLr, we
treated cells with low concentration (5 lM) of the irreversible
TrxR inhibitor auranofin (Fig 6). We determined the consequence
of TrxR1 inhibition on LDLr folding and trafficking by evaluating
the appearance of the O-linked glycosylated form of the protein
which has a decreased electrophoretic mobility compared to the
ER-localized protein (Oka et al, 2013). Trafficking of the LDLr was
followed by pulse chase analysis. In the control cells, the appear-
ance of the Golgi form of the protein occurred by 30 min with
most of the labeled protein having left the ER by 60 min (Fig 6A).
In contrast, in the auranofin-treated cells, no Golgi form was seen
after 30 min with the majority of the protein remaining in the ER
even after 60 min (Fig 6B). In the presence of auranofin, the ER-
localized protein remained as a diffuse band indicative of the
formation of non-native disulfides. This result illustrates a
dramatic effect on protein trafficking indicating a lack of correct
folding and retention of LDLr in the ER following treatment of cells
with a TrxR inhibitor.
Auranofin is generally believed to inhibit TrxR1 by modification
of the selenocysteine (Sec) residue within its active site, although
other modes of inhibition have also been suggested (Gromer et al,
1998; Angelucci et al, 2009; Lothrop et al, 2009). Interestingly, inhi-
bition of TrxR1 by chemical targeting of its Sec residue can often
lead to a gain of function of TrxR1, with an ability to act as a
NADPH oxidase thereby generating superoxide or hydrogen per-
oxide (Anestal et al, 2008). An increased generation of hydrogen
peroxide could lead to compromised protein folding in the ER. To
address this point, we also inhibited thioredoxin reductase with a
novel inhibitor (TRi-2) that was recently found to inhibit TrxR1 with
similar potency as auranofin and without inhibiting glutathione
reductase (Fig EV2) but importantly without the oxidase gain of
function (Stafford, W. et al, manuscript in preparation). Crucially in
contrast to auranofin, treatment of cells with TRi-2 does not lead to
an increased production of hydrogen peroxide (Stafford, W. et al,
manuscript in preparation). When we treated cells with TRi-2 and
carried out a pulse chase analysis of LDLr trafficking and folding,
again we saw a significant reduction in the trafficking of LDLr, with
the ER retained form migrating as a diffuse band (Fig 6C). The effect
is not as pronounced as auranofin which could be due to more effi-
cient inhibition of TrxR1 in cells with auranofin or the production of
hydrogen peroxide contributing toward the defect in protein traf-
ficking. However, the results do suggest that the effects of TrxR1
inhibition on LDLr trafficking cannot be totally explained by
increased hydrogen peroxide production by selenium compromised
forms of the enzyme. It should be noted that both auranofin and
TRi-2 can trigger cell death upon prolonged exposure, but not within
the shorter time frame utilized in our studies (Arner & Holmgren,
2000). The effects seen here on protein trafficking are likely to be
direct consequences of TrxR1 inhibition.
Finally, we determined the trafficking and secretion of a protein
lacking disulfides, a1-anti-trypsin, in the absence and presence of
auranofin to see whether the inhibitor causes a general block in
secretion. There was no difference in the rate of appearance of the
Golgi localized form or in the rate of secretion following auranofin
treatment (Fig 6D and E). Taken together, our results suggest that
TrxR1 activity is required for correct folding of proteins entering the
ER, in the reconstituted translation/translocation system as well as
in intact cells grown in culture.
Discussion
The results from this work demonstrate that the cytosolic reductive
pathway, specifically cytosolic TrxR1, is required for the reduction
in non-native disulfides within proteins entering the ER. To investi-
gate this process, we took advantage of the fact that non-native
disulfides were formed in proteins with complex disulfide linkages
in a rabbit reticulocyte lysate that could be resolved into native
disulfides upon the addition of G6P. We demonstrate that added
G6P recycles NADPH providing an electron donor for cytosolic
TrxR1, which in turn reduces Trx1. A robust TrxR1 pathway is
required to prevent the formation of non-native disulfides and,
importantly, allow the correct disulfides to form within proteins
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entering the ER. This is the first indication that such a link with
TrxR1 exists and evokes comparison between the mechanism of
disulfide formation in the ER and the periplasm of Gram-negative
bacteria. In bacteria, the membrane protein DsbD shuttles electrons
across the periplasmic membrane providing the connection between
the two distinct compartments (Kadokura et al, 2003). No such
membrane protein has been identified in mammalian cells but the
logical conclusion from our results is that such a protein exists and
will play a key role in driving the reduction in members of the PDI
family to facilitate correct protein folding.
The most novel and unique aspect of this work is that we have
been able to assay the transition from non-native to native disulfides
using an in vitro translation translocation system that reproduces
the early stages of secretory protein biogenesis. This assay contrasts
with other approaches which monitor the thiol/disulfide status of
proteins with reversible disulfides such as redox-sensitive GFP (van
Lith et al, 2011; Avezov et al, 2013) or members of the PDI family
(Appenzeller-Herzog et al, 2010). The distinction between the
assays is apposite; the former assay distinguishes two different types
of disulfide whereas the latter distinguishes between reduced or
oxidized protein. Establishing conditions that supported the forma-
tion of disulfides but prevented the resolution of non-native disul-
fides allowed us to determine the factors required to catalyze the
transition to the native disulfides.
Importantly, our results do not rule out a role for GSH in
buffering redox conditions in the ER (Bulleid & Ellgaard, 2011);
rather they address the source of the electron donor driving the
catalysis of non-native disulfide reduction. A number of studies
have demonstrated a critical role of GSH for maintaining ER redox
homeostasis. In particular, it is required to re-establish redox
conditions following reduction or oxidation of the ER (Molteni et al,
2004; Chakravarthi et al, 2006; Appenzeller-Herzog et al, 2010). In
A B C
D E
Figure 6. Inhibition of TrxR1 compromises LDLr folding and trafficking.
A–C HT1080 cells were metabolically radiolabeled with 35S for 30 min and then chased in the absence of radiolabel for up to 60 min as indicated in the presence of
vehicle (DMSO) (A), 5 lM auranofin (B), or 5 lM TRi2 (C). Radiolabeled LDLr was immunoisolated with anti-LDLr and samples separated before or after reduction as
indicated. The position of the Golgi (G) and ER forms migrating under non-reducing conditions are as indicated.
D, E HT1080 cells transfected with V5-tagged a1-antitrypsin were radiolabeled and cells chased in the absence (D) or presence (E) of auranofin as in (A–C) and
radiolabeled products immunoisolated with a V5-antibody.
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addition, it is thought to play a crucial role in regulating the activity
of Ero1 by facilitating the reduction of PDI (Cuozzo & Kaiser, 1999;
Appenzeller-Herzog et al, 2010; Kim et al, 2012). In contrast to
these roles, depletion of GSH has little or no effect on disulfide
formation or isomerization of non-native disulfides as the LDLr folds
and is trafficked normally in cells depleted of ER GSH (Tsunoda
et al, 2014), and as shown herein for b1-integrin.
In addition to providing insight into the fidelity of disulfide
formation in the ER, we also address the question of how disul-
fides are prevented from forming within proteins synthesized in
the cytosol. The role of GSH in preventing disulfide formation in
the yeast cytosol has recently been questioned due to a lack of
effect on thiol-redox maintenance following its depletion (Kumar
et al, 2011). Our results demonstrate that the Trx/TrxR1 system is
the primary reductive pathway that prevents disulfides forming in
the cytosol with even a low GSSG/GSH ratio unable to prevent
disulfide formation. Such a requirement agrees with the
lower reduction potential of thioredoxin (270 mV; Lundstrom &
Holmgren, 1993) compared to GSH (240 mV; Schafer & Buettner,
2001) and may also reflect the ability of Trx1 to bind to oxidized
substrates, thereby providing a kinetic as well as a thermodynamic
advantage over GSH. Indeed, it has recently been shown that Trx1
preferentially binds to conformationally restricted molecules such
as those containing non-native disulfides (Palde & Carroll, 2015).
The ability of Trx1 to preferentially reduce disulfides in proteins
supports the notion that cytosolic proteins whose function is regu-
lated by disulfide formation are recycled by the Trx1 rather than
GSH pathway (Toledano et al, 2013).
In summary, our results provide new insight into how redox
homeostasis is regulated in the mammalian ER and highlight the
presence of a distinct pathway for non-native disulfide bond resolu-
tion. The location of the source of reducing power is compartmen-
tally distinct from the ER raising the probability that electron
transfer across the ER membrane regulates oxidative protein folding.
The identification of NADPH as the electron donor also provides a
link between glucose metabolism and protein folding which could
influence correct protein folding and cellular stress responses
following fluctuations in glucose availability. The challenge now
will be to identify the cellular components that connect the activity
of TrxR1 in the cytosol with the reduction in the PDI family
members such as ERdj5 in the ER lumen.
Materials and Methods
Expression constructs, cell lines, and reagents
The plasmid vector encoding V5-tagged a1-antitrypsin, influenza
virus HA, bovine preprolactin, and cVIMP-cys were gifted from
Lisa Swanton (University of Manchester), Mary Jane Gething
(University of Melbourne), Stephen High (University of Manch-
ester), and Lars Ellgaard (University of Copenhagen), respectively.
The b1-integrin, hemagglutinin, and the soluble Sec-Cys variant of
SelS/VIMP (cVIMP-cys) sequences have been described previously
(Gething et al, 1980; Tiwari et al, 2011; Christensen et al, 2012).
Auranofin, carmustine, and DHEA were purchased from Sigma-
Aldrich; TRi2 synthesis will be described elsewhere (Stafford, W.
et al, manuscript in preparation). The commercial antibodies used
were anti-His (Proteintech), anti-V5-tag (Invitrogen), and 9EG7
(BD Bioscience). Antibody to LDLr (121) was a gift from Ineke
Braakman (Utrecht University; Pena et al, 2010). Purified recombi-
nant ChaC1 enzyme was a gift from David Ron (University of
Cambridge; Tsunoda et al, 2014). The plasmid containing human
thioredoxin (hTrx) with a streptavidin binding peptide (SBP) tag
was a gift from Tobias Dick (German Cancer Research Centre,
Heidelberg). Recombinant Trx protein was purified as described
previously (Schwertassek et al, 2007).
Translation reactions
DNA was transcribed and proteins translated essentially as
described previously (Jessop et al, 2007). Human b1 integrin was
transcribed using SP6 polymerase from a pSPUTK vector linearized
with EcoRV. A volume of 16.5 ll Flexi rabbit reticulocyte lysate
(RRL; Promega) was aliquoted and the following reagents added to
a final volume of 25 ll at the indicated final concentrations: KCl at
40 mM, amino acids minus methionine (Promega) at 20 lM and
EasyTagTM EXPRESS35S Protein Labelling Mix (PerkinElmer),
containing both 35S-L-methionine and 35S-L-cysteine for radiolabel-
ing of synthesized proteins at 16.3 kBq/ll. Except where stated
otherwise, the lysate mixture was also supplemented with G6P at a
final concentration of 0.5 mM. RNA transcript was added to initiate
translation. All translation reactions were incubated at 30°C in a
water bath for 60 min. Reactions were terminated by the addition of
the thiol alkylating agent N-ethylmaleimide (NEM; Thermo Scien-
tific) to a final concentration of 50 mM (Braakman et al, 1992). For
RRL samples containing no SP cells, 2 ll of the lysate sample was
added to SDS–PAGE loading buffer. Samples containing SP cells
were pulse centrifuged at 12,470 × g for 20 s to pellet the cells. The
lysate was then removed and 100 ll of KHM buffer (20 mM HEPES
buffer pH 7.2, containing 110 mM KOAc, 2 mM MgOAc) was added.
The pulse centrifugation was repeated, and the KHM buffer was
removed and SDS–PAGE loading buffer was added. The samples
were separated by SDS–PAGE. The gels were then fixed with 10%
acetic acid and 10% methanol solution for 20 min, dried, and
exposed to either a phosphorimager plate or a BioMax MR film
(Kodak); the images captured using a phosphorimager plate were
scanned using a FLA-7000 bioimager (Fujifilm).
Assessing the redox status of thioredoxin
Standard translation reactions were supplemented with SBP (strep-
tavidin binding peptide)-tagged hTrx (3.6 lM; Schwertassek et al,
2007) in the presence and absence of G6P (0.5 mM) or 20 lM aura-
nofin and incubated at 30°C for 60 min followed by alkylation with
40 mM NEM. Tagged thioredoxin was then isolated using strepta-
vidin agarose beads and eluted with 3 mM biotin in 2% SDS and
boiled for 15 min. Disulfides in isolated hTrx were reduced with
10 mM TCEP and alkylated with 25 mM AMS for 1 h in the dark.
Sample was then analyzed by immunoblotting using an anti-His
antibody.
Generation of SP cells and treatment with inhibitors
SP cells were generated from HT1080 cells as described previously
(Wilson et al, 1995). Approximately 105 cells were added per 25 ll
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translation reaction. The enzymes G6PDH, TrxR, and GR were
inhibited in the rabbit reticulocyte lysate by addition of DHEA,
auranofin or carmustine, respectively, at the indicated concentra-
tions and using a volume of solvent < 4% of total. The translation
mixture was incubated for 10 min on ice before translation
reactions were initiated by adding mRNA and incubating the
mixture at 30°C in a water bath. Where a pre-incubation of
inhibitor with SP cells was carried out, cells were isolated free of
inhibitor by centrifugation prior to resuspension in the translation
reaction.
Glutathione depletion from reticulocyte lysate, GSH, GR, and
Trx assays
Reticulocyte lysate was depleted of GSH by incubation with purified
ChaC1 (5 lM) at 20°C for 1 h. Glutathione was assayed essentially
as described previously (Tietze, 1969). Glutathione reductase was
assayed as described using recombinant human GR (Sigma; Liu &
Sturla, 2009). Thioredoxin reductase activity was measured using a
Trx1-linked spectrophotometric insulin reduction assay according to
manufacturer’s instructions (IMCO Corporation). Inhibitors were
pre-incubated with Trx and TrxR1 for 15 min before the start of the
reaction.
Metabolic labeling and pulse-chase analysis
HT1080 cells were incubated in medium lacking methionine and
cysteine for 30 min and pulse labeled for 30 min with 11 lCi/ml
of Express 35S Protein Labelling Mix (Perkin Elmer). The radio-
label was removed with PBS washes. The cells were then incu-
bated in complete medium to initiate the chase periods. To
monitor the effects of inhibition of TrxR1 on folding and secretion
of endogenous LDLR, cells were incubated either with or without
5 lΜ auranofin or 5 lΜ Tri2, during starve, label, and chase
period. Following the chase period, cells were washed twice with
PBS supplemented with 20 mM NEM and lysed in 50 mM Tris–
HCl buffer, pH 7.4 containing 1% (v/v) Triton X-100, 150 mM
NaCl, 2 mM EDTA, and 20 mM NEM. Postnuclear supernatant
was obtained by centrifugation at 4°C, and immunoisolation
was performed by pre-clearing the supernatant with protein A
Sepharose for 30 min, followed by incubation with the anti-LDLr
antibody (121) and protein A Sepharose for 16 h at 4°C. Beads
were washed three times in lysis buffer before analysis by SDS–
PAGE. Gels were fixed, dried, and radiolabeled protein visualized
by autoradiography.
HT1080 cells transfected with wild-type V5-tagged A1AT
incubated in the absence or presence of 5 lM auranofin were
pulse labeled and immunoisolated with a V5-antibody as described
above.
Expanded View for this article is available online.
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